TW202100144A - 刺激感經抑制之眼科組合物 - Google Patents

刺激感經抑制之眼科組合物 Download PDF

Info

Publication number
TW202100144A
TW202100144A TW109107480A TW109107480A TW202100144A TW 202100144 A TW202100144 A TW 202100144A TW 109107480 A TW109107480 A TW 109107480A TW 109107480 A TW109107480 A TW 109107480A TW 202100144 A TW202100144 A TW 202100144A
Authority
TW
Taiwan
Prior art keywords
component
ophthalmic composition
irritation
menthol
group
Prior art date
Application number
TW109107480A
Other languages
English (en)
Chinese (zh)
Inventor
羽賀雅俊
Original Assignee
日商樂敦製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商樂敦製藥股份有限公司 filed Critical 日商樂敦製藥股份有限公司
Publication of TW202100144A publication Critical patent/TW202100144A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW109107480A 2019-03-08 2020-03-06 刺激感經抑制之眼科組合物 TW202100144A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2019-043089 2019-03-08
JP2019043089 2019-03-08
JP2019071396 2019-04-03
JP2019-071396 2019-04-03

Publications (1)

Publication Number Publication Date
TW202100144A true TW202100144A (zh) 2021-01-01

Family

ID=72427534

Family Applications (2)

Application Number Title Priority Date Filing Date
TW109107480A TW202100144A (zh) 2019-03-08 2020-03-06 刺激感經抑制之眼科組合物
TW114131348A TW202545507A (zh) 2019-03-08 2020-03-06 刺激感經抑制之眼科組合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW114131348A TW202545507A (zh) 2019-03-08 2020-03-06 刺激感經抑制之眼科組合物

Country Status (4)

Country Link
JP (2) JPWO2020184479A1 (https=)
CN (1) CN113423428A (https=)
TW (2) TW202100144A (https=)
WO (1) WO2020184479A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI848653B (zh) * 2022-04-28 2024-07-11 英商庫博光學國際有限公司 隱形眼鏡

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4505909A (en) * 1980-09-17 1985-03-19 Bernstein Joel E Method and composition for treating and preventing irritation of the eyes
JP3597239B2 (ja) * 1994-03-31 2004-12-02 ライオン株式会社 安定な点眼剤
JPH09132526A (ja) * 1995-11-09 1997-05-20 Lion Corp 点眼剤
JPH09169642A (ja) * 1995-12-18 1997-06-30 Lion Corp テトラヒドロゾリン含有液剤
JPH09309835A (ja) * 1996-05-21 1997-12-02 Lion Corp グリチルリチン酸アルキルエステル含有薬液
JP2000327573A (ja) * 1999-05-18 2000-11-28 Taisho Pharmaceut Co Ltd 粘膜適用組成物
JP2001302518A (ja) * 2000-02-15 2001-10-31 Rohto Pharmaceut Co Ltd 官能改善方法および官能改善剤
JP2003073303A (ja) * 2001-09-05 2003-03-12 Senju Pharmaceut Co Ltd 眼局所用液剤の清涼化作用の持続方法
JP4174648B2 (ja) * 2001-11-12 2008-11-05 ロート製薬株式会社 水性組成物
JP2003183157A (ja) * 2001-12-19 2003-07-03 Lion Corp 眼科用組成物
US6982079B2 (en) * 2002-04-26 2006-01-03 Allergan, Inc. Compositions for treating hyperemia
JP2004143156A (ja) * 2002-10-01 2004-05-20 Taisho Pharmaceut Co Ltd 点眼剤
JP2004175770A (ja) * 2002-11-29 2004-06-24 Rohto Pharmaceut Co Ltd ケトチフェン及びイミダゾリン化合物含有組成物
JP5695913B2 (ja) * 2003-04-04 2015-04-08 ロート製薬株式会社 眼科用組成物
JP5661981B2 (ja) * 2004-11-26 2015-01-28 大正製薬株式会社 眼科用剤
JP5052028B2 (ja) * 2005-04-08 2012-10-17 ロート製薬株式会社 アシタザノラスト含有組成物
JP4979258B2 (ja) * 2005-04-08 2012-07-18 ロート製薬株式会社 アシタザノラスト含有水性組成物
WO2007108541A1 (ja) * 2006-03-23 2007-09-27 Senju Pharmaceutical Co., Ltd. キサンタンガムおよびブドウ糖を含有する眼科用組成物
JP2008024700A (ja) * 2006-06-23 2008-02-07 Rohto Pharmaceut Co Ltd ベルベリン含有水性組成物
JP5258329B2 (ja) * 2007-06-01 2013-08-07 ロート製薬株式会社 プラノプロフェン含有水性医薬組成物
JP2009029779A (ja) * 2007-06-29 2009-02-12 Rohto Pharmaceut Co Ltd レボカバスチン及び／又はその塩を含有する水性医薬組成物
WO2011040572A1 (ja) * 2009-09-30 2011-04-07 ロート製薬株式会社 眼科組成物
JP5595206B2 (ja) * 2009-09-30 2014-09-24 ロート製薬株式会社 眼科用液体組成物
JP2012144509A (ja) * 2011-01-12 2012-08-02 Saga Seiyaku Kk 多成分配合の点眼剤
JP5736211B2 (ja) * 2011-03-29 2015-06-17 ロート製薬株式会社 眼科用組成物
US9856196B2 (en) * 2012-01-05 2018-01-02 Kao Corporation Agent for reduction of sensory irritation
EP3219303B1 (de) * 2012-01-30 2019-11-06 Symrise AG Zubereitungen
JP2013237638A (ja) * 2012-05-15 2013-11-28 Lion Corp 眼科組成物
US20130315843A1 (en) * 2012-05-25 2013-11-28 The Procter & Gamble Company Composition for reduction of trpa1 and trpv1 sensations
JP6177594B2 (ja) * 2012-06-14 2017-08-09 ロート製薬株式会社 水性眼科組成物
JP6353365B2 (ja) * 2012-09-27 2018-07-04 千寿製薬株式会社 水性液剤
JP6177019B2 (ja) * 2013-01-31 2017-08-09 ロート製薬株式会社 点眼剤
JP5730355B2 (ja) * 2013-07-24 2015-06-10 学校法人近畿大学 Ｃｙｐ２ａ１３阻害剤
EP3093002B1 (de) * 2015-05-15 2018-04-25 Symrise AG Flüssige kühlstoffzubereitungen
JP2017119669A (ja) * 2015-10-15 2017-07-06 ロート製薬株式会社 異物感改善用眼科組成物
JP2019521189A (ja) * 2016-07-06 2019-07-25 アルゴメディックス，インク． ドライアイ、眼痛および炎症の処置のためのｔｒｐａ１アンタゴニスト

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI848653B (zh) * 2022-04-28 2024-07-11 英商庫博光學國際有限公司 隱形眼鏡
US12153288B2 (en) 2022-04-28 2024-11-26 Coopervision International Limited Contact lens
US12601929B2 (en) 2022-04-28 2026-04-14 Coopervision International Limited Contact lens

Also Published As

Publication number Publication date
TW202545507A (zh) 2025-12-01
WO2020184479A1 (ja) 2020-09-17
JPWO2020184479A1 (https=) 2020-09-17
JP2024180505A (ja) 2024-12-26
CN113423428A (zh) 2021-09-21

Similar Documents

Publication Publication Date Title
JP4694773B2 (ja) 粘膜適用液状組成物
JP2018203792A (ja) 眼の異物感改善剤
JP2011116690A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2015071553A (ja) 異物感緩和点眼剤
JP2024040401A (ja) 眼科組成物
JP7348347B2 (ja) 眼科組成物
WO2021220712A1 (ja) 眼科組成物
JP7458159B2 (ja) 眼科組成物
JP2018177820A (ja) 水性眼科組成物
JP2024166367A (ja) 眼科組成物
JP5725786B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2024180505A (ja) 刺激感が抑制された眼科組成物
JP7721324B2 (ja) ソフトコンタクトレンズ用眼科組成物
JP2025065279A (ja) ソフトコンタクトレンズ用眼科組成物
JP6687781B1 (ja) 刺激感が抑制された眼科組成物
JP2016027025A (ja) 局所粘膜適用水性組成物
JP2018168200A (ja) 眼科組成物の製造方法、眼科組成物にコンタクトレンズの摩擦を低減させる作用を付与する方法、及び眼科組成物にコンタクトレンズの眼表面への貼り付きを低減させる作用を付与する方法
JP2021105065A (ja) 異物感緩和点眼剤
HK40058186A (en) Ophthalmic composition having inhibited irritating sensation
JP6732441B2 (ja) 局所粘膜適用水性組成物
JP2021031431A (ja) 点眼剤
JP7206078B2 (ja) 摩擦によるストレス低減剤
JP6913792B2 (ja) 局所粘膜適用水性組成物
JP2021054805A (ja) 眼科用組成物及びアレルギー疾患の治療薬
JP7699426B2 (ja) 光線による障害からの細胞保護用眼科組成物